Table 4.
Enzyme | Acceptor | Feature | % Synthesis (mean ± SD)b |
---|---|---|---|
TtPNPI | HX | 2,6-Dioxo | 42.0 ± 0.5 |
BI | Backbone only | ND | |
DAP | 2,6-Diamino | ND | |
TtPNPII | A | 6-Amino | 51.0 ± 0.4 |
BI | Backbone only | ND | |
DAP | 2,6-Diamino | 41.7 ± 1.5 | |
TtPyNP | U | 2,4-Dioxo | 49.1 ± 1.3 |
5-FC | 2-Oxo,4-amino,5-fluoro | ND | |
DFU | 2,4-Difluoro | ND | |
6-tFMeU | 2,4-Dioxo,6-trifluoromethyl | ND | |
FMPy | 5-Fluoro,2-methoxy | ND | |
5-IU | 2,4-Dioxo,5-iodo | 47.8 ± 1.1 |
The transferred sugar moiety was a 2′-deoxyribose obtained by phosphorolysis of dUrd or Thd by TtPyNP. The reaction conditions for nucleoside synthesis by TtPNPI and TtPNPII were as follows: 5 mM dUrd and 2.5 mM acceptor nucleobase in sodium phosphate buffer (50 mM, pH 7.0), 10 μg of TtPyNP ml−1, 5 μg of TtPNPI or TtPNPII ml−1, and 30 min at 65°C. The reaction conditions for nucleoside synthesis by TtPyNP were as follows: 5 mM Thd and 2.5 mM acceptor in sodium phosphate buffer (50 mM, pH 7.0), 5 μg of TtPyNP ml−1, and 30 min at 65°C. Acronyms: HX, hypoxanthine; BI, benzimidazole; DAP, 2,6-diaminopurine; A, adenine; U, uracil; 5-FU, 5-fluorouracil; DFU, 2-deoxy-2-fluorouracil; 6-tMeFU, 6-trifluoromethyluracil; FMPy, 5-fluoro-2-methoxy-4(1H)pyrimidinone; 5-IU, 5-iodouracil.
Percentage of free nucleobase converted into nucleoside with respect to the total amount of nucleobase used as a substrate. ND, not detected.